Invention Grant
- Patent Title: Modified drugs for use in liposomal nanoparticles
-
Application No.: US13866956Application Date: 2013-04-19
-
Publication No.: US08545877B2Publication Date: 2013-10-01
- Inventor: Pieter Cullis , Marcel Bally , Marco Ciufolini , Norbert Maurer , Igor Jigaltsev
- Applicant: The University of British Columbia
- Applicant Address: CA Vancouver, British Columbia
- Assignee: University of British Columbia
- Current Assignee: University of British Columbia
- Current Assignee Address: CA Vancouver, British Columbia
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K31/4525
- IPC: A61K31/4525 ; A61K31/5377 ; A61K31/496

Abstract:
Drug derivatives are provided herein which are suitable for loading into liposomal nanoparticle carriers. In some preferred aspects, the derivatives comprise a poorly water-soluble drug derivatized with a weak-base moiety that facilitates active loading of the drug through a LN transmembrane pH or ion gradient into the aqueous interior of the LN. The weak-base moiety can optionally comprise a lipophilic domain that facilitates active loading of the drug to the inner monolayer of the liposomal membrane. Advantageously, LN formulations of the drug derivatives exhibit improved solubility, reduced toxicity, enhanced efficacy, and/or other benefits relative to the corresponding free drugs.
Public/Granted literature
- US20130230583A1 MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES Public/Granted day:2013-09-05
Information query
IPC分类: